Vera Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+161K	7.1%	$31.00	+$5M
Sells	5	-2.1M	92.9%	$29.29	-$61.5M
Net	-4	-1.94M	-85.7%		-$56.5M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Maha Katabi	Director	$113M	-$29.1M	-20.5%	May 15, 2024
Commodore Capital Lp	10%+ Owner	$79.2M	-$18.9M	-19.3%	Jan 10, 2024
Sofinnova Venture Partners X, L.P.	10%+ Owner	$62.4M			Feb 6, 2023
Kurt Von Emster	Director	$53.6M			May 17, 2021
Abingworth LLP	10%+ Owner	$53.3M			May 13, 2021
Carlyle Group Inc.	10%+ Owner	$53.3M			Aug 17, 2022
Longitude Prime Partners, LLC	10%+ Owner	$30.9M			Feb 6, 2023
Longitude Capital Partners IV, LLC	10%+ Owner	$30.9M			Feb 6, 2023
Marshall Fordyce	PRESIDENT AND CEO, Director	$11.6M	-$2.28M	-16.5%	Aug 28, 2024
Sean Grant	Chief Financial Officer	$2.8M	-$4.69M	-62.6%	Apr 3, 2024
Joseph R. Young	Svp, Finance, Chief Acct Offcr	$2.2M	-$1.53M	-41%	May 15, 2024
Joanne Curley	Chief Development Officer	$485K			Aug 21, 2023
Celia Lin	Chief Medical Officer	$198K			Aug 21, 2023
Christy J. Oliger	Director	$129K			Jun 7, 2024
Patrick Enright	Director				May 15, 2024
Beth C. Seidenberg	Director				May 15, 2024
Scott W. Morrison	Director				May 15, 2024
Kimball Hall	Director				May 15, 2024
Ares Trading S.A.	10%+ Owner				May 13, 2021
William D. Turner	Chief Development Officer				Jan 5, 2024
Michael Morrissey	Director				May 15, 2024
Robert Brenner	Chief Medical Officer				Jan 3, 2024
Andrew Cheng	Director				May 15, 2024
Jonathan Wolter	Chief Financial Officer				May 13, 2021
David Lee Johnson	Chief Operating Officer				Jul 1, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.